Source: Endocrine. Unidade: FM
Subjects: FATORES DE RISCO, HIPERPLASIA SUPRARRENAL CONGÊNITA, DENSIDADE ÓSSEA, COMORBIDADE
ABNT
RIGHI, Beatrice et al. Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia. Endocrine, v. 80, n. 3, p. 630-638, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53819. Acesso em: 18 nov. 2024.APA
Righi, B., Ali, S. R., Bryce, J., Tomlinson, J. W., Bonfig, W., Baronio, F., et al. (2023). Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia. Endocrine, 80( 3), 630-638. doi:10.1007/s12020-023-03330-wNLM
Righi B, Ali SR, Bryce J, Tomlinson JW, Bonfig W, Baronio F, Costa EC, Guaragna-Filho G, T'sjoen G, Cools M, Bachega TASS, Miranda MC de. Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia [Internet]. Endocrine. 2023 ; 80( 3): 630-638.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53819Vancouver
Righi B, Ali SR, Bryce J, Tomlinson JW, Bonfig W, Baronio F, Costa EC, Guaragna-Filho G, T'sjoen G, Cools M, Bachega TASS, Miranda MC de. Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia [Internet]. Endocrine. 2023 ; 80( 3): 630-638.[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53819